NO912980D0 - Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater - Google Patents

Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater

Info

Publication number
NO912980D0
NO912980D0 NO912980A NO912980A NO912980D0 NO 912980 D0 NO912980 D0 NO 912980D0 NO 912980 A NO912980 A NO 912980A NO 912980 A NO912980 A NO 912980A NO 912980 D0 NO912980 D0 NO 912980D0
Authority
NO
Norway
Prior art keywords
carbapend
fluorenoyl
derivatives
preparing
procedure
Prior art date
Application number
NO912980A
Other languages
English (en)
Other versions
NO912980L (no
Inventor
Mark L Greenlee
Frank P Dininno
Lovji D Cama
James V Heck
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/561,547 external-priority patent/US5034384A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO912980D0 publication Critical patent/NO912980D0/no
Publication of NO912980L publication Critical patent/NO912980L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO91912980A 1990-08-01 1991-07-31 Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater NO912980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/561,547 US5034384A (en) 1990-08-01 1990-08-01 2-(9-fluorenonyl)-carbapenem antibacterial agents
US59480890A 1990-10-09 1990-10-09

Publications (2)

Publication Number Publication Date
NO912980D0 true NO912980D0 (no) 1991-07-31
NO912980L NO912980L (no) 1992-02-03

Family

ID=27072675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912980A NO912980L (no) 1990-08-01 1991-07-31 Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater

Country Status (11)

Country Link
EP (1) EP0472306A1 (no)
JP (1) JP2509771B2 (no)
KR (1) KR920004388A (no)
CA (1) CA2048269A1 (no)
FI (1) FI913655A (no)
IE (1) IE912709A1 (no)
IL (1) IL98911A0 (no)
MX (1) MX9100466A (no)
NO (1) NO912980L (no)
NZ (1) NZ239186A (no)
PT (1) PT98522A (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use
US5756725A (en) * 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
JP2001500862A (ja) * 1996-09-12 2001-01-23 メルク エンド カンパニー インコーポレーテッド カルバペネム系抗菌化合物、該化合物を含む組成物および治療方法
KR20020036905A (ko) * 2000-11-11 2002-05-17 황영헌 비정상 상태 제어장치 및 방법과 그 프로그램 소스를저장한 기록매체
AU2011276157B2 (en) 2010-07-08 2016-12-22 Hans Rudolf Pfaendler Fluorescent carbapenems

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543257A (en) * 1977-10-19 1985-09-24 Merck & Co., Inc. 1-Carba-2-penem-3-carboxylic acid
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
US4600713A (en) * 1979-12-03 1986-07-15 Merck & Co., Inc. 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids
EP0277743A1 (en) * 1987-02-02 1988-08-10 Merck & Co. Inc. 2-(heteroaryliumalkyl)phenyl carbapenem antibacterial agents

Also Published As

Publication number Publication date
KR920004388A (ko) 1992-03-27
AU8151791A (en) 1992-02-06
CA2048269A1 (en) 1992-02-02
JPH05105679A (ja) 1993-04-27
FI913655A (fi) 1992-02-02
NO912980L (no) 1992-02-03
IE912709A1 (en) 1992-02-12
AU642518B2 (en) 1993-10-21
NZ239186A (en) 1993-12-23
IL98911A0 (en) 1992-07-15
EP0472306A1 (en) 1992-02-26
FI913655A0 (fi) 1991-07-31
JP2509771B2 (ja) 1996-06-26
MX9100466A (es) 1992-04-01
PT98522A (pt) 1992-06-30

Similar Documents

Publication Publication Date Title
NO913234D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO912411D0 (no) Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser.
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO914250L (no) Fremgangsmaate for fremstilling av piperazinderivater
NO920965L (no) Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
NO924028L (no) Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO914504L (no) Fremgangsmaate for fremstilling av dietere
NO914056D0 (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
NO912979D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenederivater.
NO893713D0 (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO925007D0 (no) Fremgangsmaate for fremstilling av benzofuranylimidazolderivater
NO911672D0 (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO914452D0 (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO923481D0 (no) Fremgangsmaate for fremstilling av 1-hydroksyalkyl-5-nitroimidazol
NO901069L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO901812D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
FI902356A0 (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI944968A0 (fi) Menetelmä sakkariinijohdannaisten valmistamiseksi